BIO-UV Group S.A. (EPA:ALTUV)

BIO-UV Group Statistics

Total Valuation

BIO-UV Group has a market cap or net worth of EUR 22.39 million. The enterprise value is 34.14 million.

Market Cap	22.39M
Enterprise Value	34.14M

Important Dates

The last earnings date was Friday, September 19, 2025.

Earnings Date	Sep 19, 2025
Ex-Dividend Date	n/a

Share Statistics

BIO-UV Group has 13.82 million shares outstanding.

Current Share Class	13.82M
Shares Outstanding	13.82M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+2.86%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	5.04%
Float	13.65M

Valuation Ratios

The trailing PE ratio is 22.46.

PE Ratio	22.46
Forward PE	n/a
PS Ratio	0.60
PB Ratio	0.54
P/TBV Ratio	4.37
P/FCF Ratio	8.15
P/OCF Ratio	4.70
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 16.80, with an EV/FCF ratio of 12.43.

EV / Earnings	34.25
EV / Sales	0.91
EV / EBITDA	16.80
EV / EBIT	15.22
EV / FCF	12.43

Financial Position

The company has a current ratio of 6.02, with a Debt / Equity ratio of 0.51.

Current Ratio	6.02
Quick Ratio	3.86
Debt / Equity	0.51
Debt / EBITDA	10.39
Debt / FCF	7.69
Interest Coverage	4.05

Financial Efficiency

Return on equity (ROE) is 2.68% and return on invested capital (ROIC) is 2.32%.

Return on Equity (ROE)	2.68%
Return on Assets (ROA)	1.97%
Return on Invested Capital (ROIC)	2.32%
Return on Capital Employed (ROCE)	3.29%
Revenue Per Employee	250,967
Profits Per Employee	6,690
Employee Count	149
Asset Turnover	0.53
Inventory Turnover	1.13

Taxes

In the past 12 months, BIO-UV Group has paid 308,285 in taxes.

Income Tax	308,285
Effective Tax Rate	23.62%

Stock Price Statistics

The stock price has decreased by -16.06% in the last 52 weeks. The beta is 0.43, so BIO-UV Group's price volatility has been lower than the market average.

Beta (5Y)	0.43
52-Week Price Change	-16.06%
50-Day Moving Average	1.73
200-Day Moving Average	1.90
Relative Strength Index (RSI)	36.98
Average Volume (20 Days)	9,133

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BIO-UV Group had revenue of EUR 37.39 million and earned 996,767 in profits.

Revenue	37.39M
Gross Profit	23.47M
Operating Income	2.24M
Pretax Income	1.31M
Net Income	996,767
EBITDA	2.03M
EBIT	2.24M
Earnings Per Share (EPS)	n/a

Balance Sheet

The company has 9.36 million in cash and 21.11 million in debt, giving a net cash position of -11.75 million or -0.85 per share.

Cash & Cash Equivalents	9.36M
Total Debt	21.11M
Net Cash	-11.75M
Net Cash Per Share	-0.85
Equity (Book Value)	41.39M
Book Value Per Share	n/a
Working Capital	26.22M

Cash Flow

In the last 12 months, operating cash flow was 4.77 million and capital expenditures -2.02 million, giving a free cash flow of 2.75 million.

Operating Cash Flow	4.77M
Capital Expenditures	-2.02M
Free Cash Flow	2.75M
FCF Per Share	0.20

Margins

Gross margin is 62.77%, with operating and profit margins of 6.00% and 2.67%.

Gross Margin	62.77%
Operating Margin	6.00%
Pretax Margin	3.49%
Profit Margin	2.67%
EBITDA Margin	5.43%
EBIT Margin	6.00%
FCF Margin	7.34%

Dividends & Yields

BIO-UV Group does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	4.45%
FCF Yield	12.27%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	6